The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edwards Lifesciences Corp
XETRA:EWL
|
US |
|
CSL Ltd
ASX:CSL
|
AU |
|
Sika AG
SIX:SIKA
|
CH |
|
Hanjaya Mandala Sampoerna Tbk PT
IDX:HMSP
|
ID |
|
W
|
Wells Fargo & Co
BMV:WFC
|
US |
|
LNA Sante SA
PAR:LNA
|
FR |
|
Alector Inc
NASDAQ:ALEC
|
US |
|
R
|
Ryder System Inc
F:RYD
|
US |
|
Constellation Energy Corp
NASDAQ:CEG
|
US |
|
A
|
Alibaba Health Information Technology Ltd
OTC:ALBHF
|
HK |
|
C
|
Comcast Corp
LSE:0QYF
|
US |
|
Broadridge Financial Solutions Inc
NYSE:BR
|
US |
|
Louisiana-Pacific Corp
NYSE:LPX
|
US |
|
Colefax Group PLC
LSE:CFX
|
UK |
|
3i Group PLC
LSE:III
|
UK |
|
C
|
CXMT Corporation
SSE:688825
|
CN |
|
P
|
PepsiCo Inc
XETRA:PEP
|
US |
|
Trane Technologies PLC
NYSE:TT
|
IE |
|
Asahi Group Holdings Ltd
TSE:2502
|
JP |
|
Italgas SpA
OTC:ITGGF
|
IT |
|
APA Group
F:PJZ
|
AU |
|
H
|
Heidelberg Materials AG
MIL:1HEI
|
DE |
|
W
|
Woolworths Group Ltd
OTC:WOLWF
|
AU |
|
Southern Co
NYSE:SO
|
US |
Edwards Lifesciences Corp (EWL)’s 12-month stock price forecast through November 2027 has a consensus target of €93.03, implying 3% upside. The forecast is based on price targets from 30 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
EWL is 93.03 EUR with a low forecast of 77.91 EUR and a high forecast of 111.49 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more